Navigation Links
German High Court Rules in Favor of AmniSure® as New European Guidelines Published
Date:3/4/2011

KARLSRUHE, Germany, March 4, 2011 /PRNewswire/ -- The High Court of Germany (Bundesgerichtshof) handed down a final ruling in favor of AmniSure® International, LLC in its dispute with the Finnish company Medix Biochemica. The court upheld the German Patent Court's ruling that the patent associated with Medix's ActimPROM test is null and void due to its lack of an inventive step. Medix is expected to pay AmniSure® an undisclosed amount to be determined by the courts.

"We are extremely pleased with the decision of the German High Court," said Dr. Michael Friedman, President and CEO of AmniSure® International. "The Court's decision coincided with the publication of the new peer-reviewed Guidelines of the European Association of Perinatal Medicine, which hailed the AmniSure® test as the 'most useful tool' and the 'most accurate bedside test' for diagnosing ruptured fetal membranes(1). The Court's decision closes a chapter for us by bringing a seven-year-long litigation, initiated by Medix, to its rightful conclusion. The publication of the European Guidelines, meanwhile, opens a new chapter for us by establishing the AmniSure® test as the new benchmark for diagnosing ruptured fetal membranes."

(1) The Journal of Maternal-Fetal and Neonatal Medicine, March 2011. ISSN 1476-7058

About AmniSure® International, LLCAmniSure® International, LLC (http://www.amnisure.com) is a medical device company that operates internationally with headquarters in Boston, MA. AmniSure® International pioneered a rapid diagnostic device, AmniSure® ROM Test, which solves a long-standing problem in obstetrics and is rapidly becoming a new global standard in maternal fetal medicine. Contact:info@amnisure.com  617-234-4441 Tel.This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE AmniSure International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
2. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
3. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
4. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
5. Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
6. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
7. WATCHMAN® Receives German Reimbursement Coverage
8. ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firms Growing Client Base in Germany
9. Otix Global, Inc. to Discontinue German Operations
10. German District Court Finds RENASYS™ GO NPWT System Non-infringing
11. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... to oncology professionals, has added National Cancer Institute-designated University of Virginia (UVA) ... In this new partnership, OncLive’s editorial and marketing teams will publicize and promote ...
(Date:5/26/2016)... ... May 26, 2016 , ... A health conscious snack that ... Dough Bar, has ignited an undeniable buzz in the protein product community by ... just any doughnut.  These doughnuts are packed with 11 grams of protein and made ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... provide strategic sales leadership and to further develop their rapidly expanding portfolio of ... Business Administration with a concentration in Marketing and an M.B.A. with concentration in ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... efforts for several years, and the efforts have paid off. Since implementation ... new standards of care to enhance perioperative patient experiences and reduce costly complications. ...
(Date:5/26/2016)... ... , ... Dr. LeRoy Perry’s recently authored whitepaper, “Tech Neck and ROI (return ... of users, hundreds of millions of whom are coming into the workplace with pain ... common action of looking down at hand-held technology devices (tablets, smartphones) for extended periods ...
Breaking Medicine News(10 mins):